Compare IAC/Interactivecorp (PPLI) vs Zimmer Biomet Holdings Inc (ZBH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
IAC/Interactivecorp vs Zimmer Biomet Holdings Inc — how do they compare? IAC/Interactivecorp trades at $40.88 (market cap $3.05B), while Zimmer Biomet Holdings Inc trades at $89.14 (market cap $16.95B). The key difference: Zimmer Biomet Holdings Inc is far larger — about 5.6× IAC/Interactivecorp's market cap, and Zimmer Biomet Holdings Inc pays a 1.08% dividend while IAC/Interactivecorp pays none. Which is the better fit depends on your goals — on Pluang, investors hold IAC/Interactivecorp for 79 Days and Zimmer Biomet Holdings Inc for 89 Days on average.
| PPLI | ZBH | |
|---|---|---|
Market Cap | $3.05B | $16.95B |
Volume | 931,019 | 2,505,240 |
Sector | Media | Health |
52-Week High | $47.62 | $103.98 |
52-Week Low | $31.52 | $79.58 |
Typical Hold Time | 79 Days | 89 Days |
Enterprise Value | $3.53B | $24.02B |
Dividend Yield | — | 1.08% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
PPLI trades at $40.89, up 0.74% with strong analyst support (71% buy ratings) amid MGM acquisition speculation. The stock shows bullish technical momentum with recent earnings volatility - missing Q4 2025 and Q1 2026 but beating Q2 2026 expectations. Revenue declined to $2.39B in 2025 while maintaining healthy gross margins of 66.35%. The company's valuation appears attractive with P/E of 6.92 and P/B of 0.6, though negative cash flow of -$820M in 2025 raises concerns.
The outlook remains positive given potential MGM bid and improving 2026 profit projections (14.12% margin). Key risks include volatile earnings, declining revenue trends, and negative cash flow. With strong institutional support and takeover speculation, the stock offers upside potential but requires monitoring of operational turnaround and acquisition developments.
Zimmer Biomet (ZBH) trades at $89.14, up 0.73% today, with a bearish technical signal but strong recent earnings beats. The stock shows robust fundamentals with a 69.87% gross margin and 2025 revenue of $8.23B, though net income margin has declined from 2023 peaks. Analyst consensus is a Buy with a $103.11 target, indicating potential upside, supported by a steady dividend and institutional accumulation.
The outlook is mixed: valuation metrics like a P/E of 21.57 appear reasonable, and earnings momentum is positive, but technical weakness and rising debt-to-asset ratios pose risks. Investment appeal hinges on execution of commercial transformations and procedure volume recovery, balancing growth prospects against competitive and operational headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About IAC/Interactivecorp
IAC Inc is an Internet media company with segments that include Angi (47% of total revenue), Dotdash (10%), search (24%), and emerging and other (19%). The firm spun off the narrow-moat dating app provider Match Group in second-quarter 2020 and the no-moat video software provider Vimeo in second-quarter 2021.
Read more on PPLI →About Zimmer Biomet Holdings Inc
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.
Read more on ZBH →
